Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.3m
Position in Universe th / 6853

BUZZ-Juniper Pharma: Surges on buyout deal

Tue 3rd July, 2018 11:55am
** Drug developer's shares  JNP.O  jump 31.6 pct to $11.45
in premarket trading
    ** Stock second biggest pct gainer among Nasdaq-listed
stocks 
    ** Contract manufacturing organization Catalent Inc  CTLT.N 
said it will buy JNP for $11.50 per share in cash, a premium of
about 32 pct to its last close
    ** Deal values Juniper at about $127.7 mln, according to TR
calculations  urn:newsml:reuters.com:*:nL4N1TZ35B
    ** Transaction includes JNP's UK-based Juniper Pharma
services unit, expanding CTLT's drug product capabilities 
    ** JNP hit a more than 1-1/2 yr high in January after it
said it was reviewing strategic alternatives and shares had
risen nearly 80 pct YTD

 (Reporting by Manas Mishra in Bengaluru)
 ((Reuters Messaging:
manas.mishra.thomsonreuters.com@reuters.net))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.